source
- Vertex pays $28 million upfront to AbCellera for autoimmune T-cell engager collaborationVertex Pharmaceuticals has entered a collaboration with AbCellera, paying an upfront sum of $28 million to access the latter’s T-cell engager platform for autoimmune disease programs. Under the ag…
- NSF launches $47 million pilot to create joint university-industry Ph.D. programs for life scientistsThe National Science Foundation, with funding announced by the Trump administration, is testing a new Ph.D. training model that blends academic study with industry experience. The $47 million pilo…